Skip to main content

In-Utero Sugar Restriction Cuts Offspring's Risk for Diabetes, Hypertension

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 7, 2024.

By Lori Solomon HealthDay Reporter

THURSDAY, Nov. 7, 2024 -- Sugar restriction during the first 1,000 days after conception lowers a child's risk for later developing type 2 diabetes and hypertension, according to a study published online Oct. 31 in Science.

Tadeja Gracner, Ph.D., from the University of Southern California in Los Angeles, and colleagues examined the impact of sugar exposure within 1,000 days since conception on diabetes and hypertension. The analysis used a quasi-experimental design based on data from adults conceived just before and after the end of the United Kingdom sugar rationing in September 1953, which restricted sugar intake to levels within current dietary guidelines. Consumption nearly doubled immediately after rationing ended.

The researchers found that early-life rationing reduced diabetes and hypertension risk by about 35 and 20 percent, respectively. Similarly, rationing delayed disease onset by four and two years, respectively. With in-utero exposure restriction, protection was seen and increased with postnatal sugar restriction, especially after six months when solid foods likely began. One-third of the risk reduction was accounted for by in-utero sugar rationing.

"Parents need information about what works, and this study provides some of the first causal evidence that reducing added sugar early in life is a powerful step towards improving children's health over their lifetimes," coauthor Claire Boone, from McGill University in Montreal and the University of Chicago, said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted November 2024

Read this next

Semaglutide Plus Intensive Behavioral Therapy Most Beneficial for Weight Loss

FRIDAY, May 23, 2025 -- Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in...

Childhood Cancer Survivors Have Increased Risk for CKD, Hypertension

THURSDAY, May 22, 2025 -- Childhood cancer survivors (CCS) have an increased risk for chronic kidney disease (CKD) and hypertension, according to a study published online May 19...

GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression

MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.